StockData
Evotec SE logo

Evotec SE (EVO) stock

EVONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as EVOTF
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Apr 8, 2026Score 4/30
$1.32−0.13 (-8.97%)

Close on Nov 20, 2026Market cap $469.34MP/E –Yield –

Evotec free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2025 it was -€81.72M. The highest annual figure on record is €24.46M in fiscal 2022.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-€81.72M–
FY2024Dec 31, 2024-€99.25M–
FY2023Dec 31, 2023-€176.88M-823.2%
FY2022Dec 31, 2022€24.46M+219.4%
FY2021Dec 31, 2021€7.66M–
FY2020Dec 31, 2020-€54.35M-598.9%
FY2019Dec 31, 2019€10.89M–

More Evotec figures

See a number that looks wrong?